Business
Europe is lashing out like a wounded animal but its injuries are self-inflicted – Sydney Morning Herald
Fifty-five weeks have passed since coronavirus first swept across Europe but the past seven days will go down as some of the most damaging.

AstraZeneca is not above criticism but its European factories face extraordinary demand from a vaccine-hungry world, from the nations of Africa awaiting emergency supply to Australia, which will inoculate the bulk of the population with the Oxford jab. The British-Swedish firm is also pumping out the doses on a not-for-profit basis under its agreement with the University of Oxford, so there is little financial incentive for it to divert vaccines to other countries at the expense of the EU.
AstraZeneca…
-
Business20 hours ago
Warning! These ASX 200 shares were just downgraded
-
Business13 hours ago
Macquarie tips 14% upside for this ASX tech stock
-
Business10 hours ago
Top brokers name 3 ASX shares to buy today 27 August 2025
-
Business13 hours ago
This ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.